For easy, more comfortable injections from start to finish.
The latest innovation from BD Diabetes Care, a worldwide leader in diabetes care
The updated design of BD Nano 2nd Gen Pen Needles now with patented features that include:
Wider outer cover that makes it easier to attach to your pen injection device1
Larger, green, inner needle shield that's easier to grip and remove before you inject1
Comfortable, contoured needle base that helps you hold the pen against your skin, without wobbling, also providing a more reliable injection1,2*^
Existing proven benefits of BD Ultra-Fine PentaPoint Comfort and EasyFlow Technology3,4
The ergonomic design of BD Nano 2nd Gen Pen Needles provides an easier and more comfortable injection experience1**
Covered by most health plans at the lowest co-pay, including Medicare Part Dt.
Compatible with widely used pen injection devices5
Please refer to the manufacturer's insert that came with the pen device
Non-Toxic, Non-Pyrogenic
Not made with natural rubber latex
Sterile single use pen needles
Use once, remove and properly contain
Made in Ireland.
___________________________________
* Compared to other pen needles studied. ^ Reliability results from swine studies showing insulin under the skin. **Results from clinical study assessing patient preferences and feedback compared to other pen needles studied. t Co-pays and preferred status vary by plan. References: 1.Whooley S, Briskin T, Gibney MA, et al. Evaluating the User Performance and Experience with a Re-Engineered 4 mm x 32G Pen Needle: A Randomized Trial with Similar Length/Gauge Needles. Diabetes Ther. 2019;10(2):697-712. 2.Rini C, Roberts BC, Morel D, et al. Evaluating the Impact of Human Factors and Pen Needle Design on Insulin Pen Injection. J Diabetes Sci Technol. 2019;13(3):533-545. 3.Aronson R et al. Clin. Therap. 2013;35(7):923-933. 4.Hirsch L, et al. Jrnl of Diab. Sci. and Tech. 2012;6(2):328-335 5.BD Compatibility Confirmation for Pen Needles and Pen Injector Manufacturers, Document Number: 149OTH-0004-20, Rev P, Dated 07 February 2020. U.S. Patent Nos. D787054, D825749, D804023 and other patents pending.
